Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
36.88
0.37 (1.01%)
At close: Aug 15, 2025, 3:59 PM
36.87
-0.03%
After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
39.78M 45.56M 49.48M 46.09M 11.59M 38.33M 26.61M 38.46M 34.3M 29.48M 48.51M 87.94M 23.53M 21.48M 22.71M -9.62M 14.12M 7.39M
Depreciation & Amortization
5.97M 5.97M 5.97M 5.97M 6.05M 6.12M 6.13M 6.11M 6.06M 6.06M 6.07M 6.06M 6.05M 5.2M 4.76M 4.67M 4.73M 4.68M
Stock-Based Compensation
11.46M 12.5M 10.07M 11.05M 11.09M 10.39M 8.86M 7.99M 7.65M 7.2M 7.26M 7.01M 7.28M 4.63M 4.2M 4.25M 3.91M 3.3M
Other Working Capital
n/a -7.46M 14.42M 23.47M -17.43M -11.67M 32.6M 10.44M 4.77M -1.26M -25.67M 36.99M 7.52M -5.97M 9.7M 3.81M 5.21M -3.26M
Other Non-Cash Items
28.61M -25.73M 943K 518K 62.95M 31.39M 2.3M 10.72M 323K -493K 1.11M 425K 889K 1.06M 603K 850K 617K 614K
Deferred Income Tax
-6.49M -4.31M -6.71M -4.83M -14.28M -3.48M 1.12M -6.91M -4.19M -3.44M -4.26M -81.68M n/a n/a n/a 26.15M n/a n/a
Change in Working Capital
n/a n/a 15.82M 11.7M -14.51M -20.33M 31.64M 6.73M -7.08M 3.74M -32.01M 35.45M -4.02M -3.52M 5.26M 4.12M -5.3M -3.45M
Operating Cash Flow
79.33M 33.99M 75.56M 70.5M 42.62M 31.14M 76.67M 63.1M 37.06M 42.56M 26.68M 55.2M 33.73M 28.85M 37.53M 30.42M 18.07M 12.53M
Capital Expenditures
-4K -128K -513K -3K -632K -5K -107K n/a -205K n/a 40.17M -86K -41K -40.05M 100.3M -93K -201K -100M
Cash Acquisitions
n/a n/a n/a n/a -33.07M n/a -44.53M n/a 7.57M n/a n/a -872K n/a n/a -100M n/a n/a n/a
Purchase of Investments
-23.9M -19.13M -35.69M -23.29M -21.21M -25.11M -21.61M -33.01M -25.07M -47.78M -55.09M -33.23M -22.41M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
19.32M 21.62M 30.01M 24.04M 25.56M 18.93M 22.62M 32.2M 17.5M 45.99M 8.2M 872K n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-15M n/a -1M n/a -25.5M -6.18M 7.57M -813K -7.57M -1.79M -40.17M 872K -22.41M -40M 100M n/a n/a -100M
Investing Cash Flow
-19.59M 2.36M -7.19M 745K -54.86M -6.19M -36.06M -813K -7.77M -1.79M -46.9M -32.45M -22.45M -40.05M 100.3M -93K -201K -100M
Debt Repayment
n/a -3.75M -3.75M -3.75M -3.75M -3.75M -3.75M 200M -500K -500K -500K -500K -500K -500K -500K -22M n/a n/a
Common Stock Repurchased
n/a n/a n/a 269K -269K n/a -50M -50M -514K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a -55.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.06M -352K 1.01M 2.58M 304K 116K 55.49M -255.1M 161K 3.91M 3.16M 2.55M 1.25M 1.88M 7.57M 21.69M 648K 12K
Financial Cash Flow
-2.69M -352K -2.74M -1.18M -3.45M -3.63M -53.52M -55.1M -339K 3.41M 2.66M 2.05M 750K 1.38M 7.07M -313K 648K 12K
Net Cash Flow
57.05M 36M 65.63M 70.34M -15.69M 21.32M -12.92M 7.19M 28.95M 44.18M -17.56M 24.81M 12.03M -9.81M 44.6M 30.02M 18.52M -87.46M
Free Cash Flow
79.32M 33.86M 75.05M 70.5M 41.98M 31.14M 76.56M 63.1M 36.86M 42.56M 66.85M 55.12M 33.69M -11.19M 137.83M 30.33M 17.87M -87.47M